NASDAQ:CLIN - Nasdaq - US1844931048 - Common Stock - Currency: USD
TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 1.06M | 1.37M | 0.00 | |||
Selling, General, and Administrative Expenses | 320.00K | 300.00K | N/A | |||
Operating Income | -1.06M | -1.37M | 0.00 | |||
Interest Income/Expense | 7.69M | 3.29M | N/A | |||
Non Recurring Items | -1.24M | -1.21M | N/A | |||
Income Before Taxes | 5.39M | 710.00K | 0.00 | |||
Income Tax | 1.22M | 650.00K | N/A | |||
Net Income | 4.16M | 60.00K | 0.00 | |||
Per Share Data | ||||||
EPS Diluted Total Ops | 0.14 | 0.00 | 0.00 | |||
Statistics |
All data in USD